Abstract
Arteriosclerosis, restenosis, and hypertension as well as a number of other vascular diseases are characterized by vascular smooth muscle cell proliferation.1-4 Smooth muscle cell growth is regulated by specific factors released from blood cells,1-5 by the vessel wall cells3,6 and by natural compounds, such as tocopherols. Active oxygen species (i.e., O2, H2O2, and OH) may act as vascular smooth muscle growth factors by inducing proto-oncogene expression and DNA synthesis,7,8 and antioxidants can retard atherosclerosis and foam cell formation as shown in animal model,9,10 and human studies.11-14 Tocopherols, well-established natural antioxidants, may in some cases stimulate cell proliferation by preventing the formation of growth-inhibitory lipid peroxides.15-19 In addition to having antioxidant properties, RRR-α-tocopherol is a cell growth inhibitor, this effect being unrelated with its radical scavenger properties.20,21 Parallel to the inhibition of cell proliferation, RRR-α-tocopherol has been shown to inhibit protein kinase C activity in smooth muscle cells.20,21 The mechanism of this inhibition appears to be related with a diminished phosphorylation of protein kinase C-α.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Raines, E. W., and R. Ross. 1993. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart. J. 69: S30–S37.
Badimon, J. J., V. Fuster, J. H. Chesebro, and L. Badimon. 1993. Coronary atherosclerosis: a multifactorial disease. Circulation 87: 113–116.
Fuster, V., L. Badimon, J. J. Badimon, and J. H. Chesebro. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N. Engl. J. Med. 326: 310–318.
Fuster, V., L. Badimon, J. J. Badimon, and J. H. Chesebro. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N. Engl. J. Med. 326: 242–250.
Schwartz, S. M., R. L. Heimark, and M. W. Majesky. 1990. Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70: 1177–1209.
Ross, R., and L. Agius. 1992. The process of atherogenesis—cellular and molecular interaction: from experimental animal models to humans. Diabetologia 35: S34–S40.
Rao, G. N., and B. C. Berk. 1992. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70: 593–599.
Rao, G. N., B. Lassegue, K. K. Griendling, R. W. Alexander, and B. C. Berk. 1993. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: role of protein kinase C. Nucleic Acids Res. 21: 1259–1263.
Kita, T., Y. Nagano, M. Yokode, K. Ishii, N. Kume, A. Ooshima, H. Yoshida, and C. Kawai. 1987. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 84: 5928–5931.
Bjorkhem, I., A. Henriksson Freyschuss, O. Breuer, U. Diczfalusy, L. Berglund, and P. Henriksson. 1991. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11: 15–22.
Jialal, I., and C. J. Fuller. 1993. Oxidized LDL and antioxidants. Clin. Cardiol. 16: I6–I9.
Gey, K. F. 1990. The antioxidant hypothesis of cardiovascular disease: epidemiology and mechanisms. Biochem. Soc. Trans. 18: 1041–1045.
Rimm, E. B., M. J. Stampfer, A. Ascherio, E. Giovannucci, G. A. Colditz, and W. C. Willett. 1993. Vitamin E consumption and the risk of coronary heart disease in men (see comments). N. Engl. J. Med. 328: 1450–1456.
Stampfer, M. J., C. H. Hennekens, J. E. Manson, G. A. Colditz, B. Rosner, and W. C. Willett. 1993. Vitamin E consumption and the risk of coronary disease in women (see comments). N. Engl. J. Med. 328: 1444–1449.
Morisaki, N., K. Yokote, and Y. Saito. 1992. Atherosclerosis from a viewpoint of arterial wall cell function: relation to vitamin E. J. Nutr. Sci. Vitaminol. Spec. No: 196–199.
Lindsey, J. A., H. F. Zhang, H. Kaseki, N. Morisaki, T. Sato, and D. G. Cornwell. 1985. Fatty acid metabolism and cell proliferation. VII. Antioxidant effects of tocopherols and their quinones. Lipids 20: 151–157.
Gavino, V. C., J. S. Miller, S. O. Ikharebha, G. E. Milo, and D. G. Cornwell. 1981. Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J. Lipid Res. 22: 763–769.
Kuzuya, M., M. Naito, C. Funaki, T. Hayashi, K. Yamada, K. Asai, and F. Kuzuya. 1991. Antioxidants stimulate endothelial cell proliferation in culture. Artery 18: 115–124.
Morisaki, N., J. M. Stitts, L. Bartels Tomei, G. E. Milo, R. V. Panganamala, and D. G. Cornwell. 1982. Dipyridamole: an antioxidant that promotes the proliferation of aorta smooth muscle cells. Artery 11: 88–107.
Chatelain, E., D. O. Boscoboinik, G. M. Bartoli, V. E. Kagan, F. K. Gey, L. Packer, and A. Azzi. 1993. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta 1176: 83–89.
Ozer, N. K., P. Palozza, D. Boscoboinik, and A. Azzi. 1993. d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett. 322: 307–310.
Azzi, A., D. Boscoboinik, and C. Hensey. 1992. The protein kinase C family. Eur. J. Biochem. 208: 547–557.
Chakraborti, S., and J. R. Michael. 1993. Role of protein kinase C in oxidant-mediated activation of phospholipase A2 in rabbit pulmonary arterial smooth muscle cells. Mol. Cell. Biochem. 122: 9–15.
Chakraborti, S., S. K. Batabyal, G. Dutta, and J. R. Michael. 1992. Role of serine esterase in hydrogen peroxide-mediated activation of phospholipase A2 in rabbit pulmonary arterial smooth muscle cells. Ind. J. Biochem. Biophys. 29: 477–481.
Rao, G. N., B. Lassègue, K. K. Griendling, and R. W. Alexander. 1993. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene 8: 2759–2764.
Gopalakrishna, R., and W. B. Anderson. 1991. Reversible oxidative activation and inactivation of protein kinase C by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys. 285: 382–387.
Palumbo, E. J., J. D. Sweatt, S. J. Chen, and E. Klann. 1992. Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem. Biophys. Res. Commun. 187: 1439–1445.
Azzi, A., D. Boscoboinik, and N. K. Ozer. 1994. Vascular smooth muscle cells: regulation and deregulation by reactive oxygen species, pp. 423–445. In C. K. Sen, L. Packer, and O. Hänninen (eds.), Exercise and Oxygen Toxicity. Elsevier Science Publishers B. V., Amsterdam.
Abate, C., L. Patel, F. J. Rauscher, and T. Curran. 1990. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249: 1157–1161.
Toledano, M. B., and W. J. Leonard. 1991. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl Acad. Sci. USA 88: 4328–4332.
Bannister, A. J., A. Cook, and T. Kouzarides. 1991. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene 6: 1243–1250.
Frame, M. C., N. M. Wilkie, A. J. Darling, A. Chudleigh, A. Pintzas, J. C. Lang, and D. A. Gillespie. 1991. Regulation of AP-l/DNA complex formation in vitro. Oncogene 6: 205–209.
Derijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025–1037.
Engelberg, D., C. Klein, H. Martinetto, K. Struhl, and M. Karin. 1994. The UV response involving the Ras signaling pathway and AP-1 transcription factors is conserved between yeast and mammals. Cell 77: 381–390.
Minden, A., A. Lin, T. Smeal, B. Dérijard, M. Cobb, R. Davis, and M. Karin. 1994. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14: 6683–6688.
Clark, J. D., L. L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. Y. Lin, N. Milona, and J. L. Knopf. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell 65: 1043–1051.
Burch, R. M, A. Luini, and J. Axelrod. 1986. Phospholipase A2 and phospholipase C are activated by distinct GTP-binding proteins in response to alpha 1-adrenergic stimulation in FRTL5 thyroid cells. Proc. Natl. Acad. Sci. USA 83: 7201–7205.
Lin, L. L., M. Wartmann, A. Y. Lin, J. L. Knopf, A. Seth, and J. R. Davis. 1993. cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269–278.
Glaser, K. B., A. Sung, J. Bauer, and B. M. Weichman. 1993. Regulation of eicosanoid biosynthesis in the macrophage. Involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors. Biochem. Pharmacol. 45: 711–721.
Gupta, S. K., E. Diez, L. E. Heasley, S. Osawa, and G. L. Johnson. 1990. A G protein mutant that inhibits thrombin and purinergic receptor activation of phospholipase A2. Science 249: 662–666.
Rao, G. N., M. S. Runge, and R. W. Alexander. Hydrogen peroxide activation of cytosolic phospholipase A2 in vascular smooth muscle cells. Biochim. Biophys. Acta 1265: 67–72.
Mahoney, C. W., and K. P. Huang. 1994. Molecular and catalytic properties of protein kinase C., pp. 16–63. In J. Kuo (ed.), Protein Kinase C. Oxford University Press, New York.
Gopalakrishna, R., and W. B. Anderson. 1989. Ca2+-and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc. Natl. Acad. Sci. USA 86: 6758–6762.
Kass, G. E., S. K. Duddy, and S. Orrenius. 1989. Activation of hepatocyte protein kinase C by redox-cycling quinones. Biochem. J. 260: 499–507.
Gopalakrishna, R., Z. H. Chen, and U. Gundimeda. 1993. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J. Biol. Chem. 268: 27180–27185.
Siflinger Birnboim, A., M. S. Goligorsky, P. J. Del Vecchio, and A. B. Malik. 1992. Activation of protein kinase C pathway contributes to hydrogen peroxideinduced increase in endothelial permeability (see comments). Lab. Invest. 67: 24–30.
Whisler, R. L., M. A. Goyette, I. S. Grants, and Y. G. Newhouse. 1995. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in Jurkat T cells. Arch. Biochem. Biophys. 319: 23–35.
Cantoni, O., D. Boscoboinik, M. Fiorani, B. Stäuble, and A. Azzi. 1996. The phosphorylation state of MAP-kinases modulates the cytotoxic response of smooth muscle cells to hydrogen peroxide. FEBS Lett. 389: 285–288.
Fiorani, M., O. Cantoni, A. Tasinato, D. Boscoboinik, and A. Azzi. 1995. Hydrogen peroxide-and fetal bovine serum-induced dna synthesis in vascular smooth muscle cells: positive and negative regulation by protein kinase C isoforms. Biochim. Biophys. Acta 1269: 98–104.
Stauble, B., D. Boscoboinik, A. Tasinato, and M. Azzi. 1994. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-α-tocopherol in vascular smooth muscle cells. Eur. J. Biochem. 226: 393–402.
Sasaguri, T., C. Kosaka, M. Hirata, J. Masuda, K. Shimokado, M. Fujishima, and J. Ogata. 1993. Protein kinase C-mediated inhibition of vascular smooth muscle cell proliferation: the isoforms that may mediate Gl/S inhibition. Exp. Cell. Res. 208: 311–320.
Sasaguri, T., C. Kosaka, K. Zen, J. Masuda, K. Shimokado, and J. Ogata. 1995. Protein kinase C isoforms that may mediate Gl/S inhibition in cultured vascular smooth muscle cells. Ann. N.Y. Acad. Sci. 748: 590–591.
Berra, E., M. T. Diaz Meco, J. Dominguez, M. M. Municio, L. Sanz, J. Lozano, R. S. Chapkin, and J. Moscat. 1993. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell 74: 555–563.
Nakanishi, H., K. A. Brewer, and J. H. Exton. 1993. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 268: 13–16.
Pongracz, J., P. Clark, J. P. Neoptolemos, and J. M. Lord. 1995. Expression of protein kinase C isoenzymes in colorectal cancer tissue and their differential activation by different bile acids. Int. J. Cancer 61: 35–39.
Cadena, D. L., and G. N. Gill. 1992. Receptor tyrosine kinases. FASEB J. 6: 2332–2337.
Toyoshima, K., Y. Yamanashi, K. Inoue, K. Semba, T. Yamamoto, and T. Akiyama. 1992. Protein tyrosine kinases belonging to the src family. CIBA Found. Symp. 164: 240–248.
Glenney, J. R., Jr. 1992. Tyrosine-phosphorylated proteins: mediators of signal transduction from the tyrosine kinases. Biochim. Biophys. Acta 1134: 113–127.
Chen, Y. X., D. C. Yang, A. B. Brown, Y. Jeng, A. Tatoyan, and T. M. Chan. 1990. Activation of a membrane-associated phosphatidylinositol kinase through tyrosine-protein phosphorylation by naphthoquinones and orthovanadate. Arch. Biochem. Biophys. 283: 184–192.
Fialkow, L., C. K. Chan, S. Grinstein, and G. P. Downey. 1993. Regulation of tyrosine phosphorylation in neutrophils by the NADPH oxidase. Role of reactive oxygen intermediates. J. Biol. Chem. 268: 17131–17137.
Chan, T. M., E. Chen, A. Tatoyan, N. S. Shargill, M. Pleta, and P. Hochstein. 1986. Stimulation of tyrosine-specific protein phosphorylation in the rat liver plasma membrane by oxygen radicals. Biochem. Biophys. Res. Commun. 139: 439–445.
Chen, Y., and T. M. Chan. 1993. Orthovanadate and 2,3-dimethoxy-l,4-naphthoquinone augment growth factor-induced cell proliferation and c-fos gene expression in 3T3-L1 cells. Arch. Biochem. Biophys. 305: 9–16.
Zor, U., E. Ferber, P. Gergely, K. Szucs, V. Dombradi, and R. Goldman. 1993. Reactive oxygen species mediate phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation: potentiation by vanadate. Biochem. J. 295: 879–888.
Nakamura, K., T. Hori, N. Sato, K. Sugie, T. Kawakami, and J. Yodoi. 1993. Redox regulation of a src family protein tyrosine kinase p561ck in T cells. Oncogene 8: 3133–3139.
Kanner, S. B., T. J. Kavanagh, A. Grossmann, S. L. Hu, J. B. Bolen, P. S. Rabinovitch, and J. A. Ledbetter. 1992. Sulfhydryl oxidation down-regulates T-cell signaling and inhibits tyrosine phosphorylation of phospholipase C gamma 1. Proc. Natl. Acad. Sci. USA 89: 300–304.
Toyoshima, H., H. Kozutsumi, Y. Maru, K. Hagiwara, A. Furuya, H. Mioh, N. Hanai, F. Takaku, Y. Yazaki and H. Hirai. 1993. Differently spliced cDNAs of human leukocyte tyrosine kinase receptor tyrosine kinase predict receptor proteins with and without a tyrosine kinase domain and a soluble receptor protein. Proc. Natl. Acad. Sci. USA 90: 5404–5408.
Bauskin, A. R., I. Alkalay, and Y. Ben Neriah. 1991. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 66: 685–696.
Guy, G. R., J. Cairns, S. B. Ng, and Y. H. Tan. 1993. Inactivation of a redoxsensitive protein Phosphatase during the early events of tumor necrosis factor/ interleukin-1 signal transduction. J. Biol. Chem. 268: 2141–2148.
Keyse, S. M., and E. A. Emslie. 1992. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine Phosphatase. Nature 359: 644–647.
Alessi, D. R., C. Smythe, and S. M. Keyse. 1993. The human CL100 gene encodes a Tyr/Thr-protein Phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogene 8: 2015–2020.
Keyse, S. M. 1995. An emerging family of dual specificity MAP kinase phosphatases. Biochim. Biophys. Acta 1265: 152–160.
Sullivan, S. G., D. T. Chiu, M. Errasfa, J. M. Wang, J. S. Qi, and A. Stern. 1994. Effects of H2O2 on protein tyrosine Phosphatase activity in HER14 cells. Free Rad. Biol. Med. 16: 399–403.
Seger, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9: 726–735.
Egan, S. E., and R. A. Weinberg. 1993. The pathway to signal achievement (news). Nature 365: 781–783.
Blumer, K. J., and G. L. Johnson. 1994. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19: 236–240.
Cobb, M. H., and E. J. Goldsmith. 1995. How MAP kinases are regulated. J. Biol. Chem. 270: 14843–14846.
Clarke, P. R. 1994. Signal transduction. Switching off MAP kinases. Curr. Biol. 4: 647–650.
Duff, J. L., B. P. Monia, and B. C. Berk. 1995. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase Phosphatase (MKP-1) in vascular smooth muscle cells. Effect of antinomycin D and antisense oligonucleotides. J. Biol. Chem. 270: 7161–7166.
Stevenson, M. A., S. S. Pollock, C. N. Coleman, and S. K. Calderwood. 1994. X-irradiation, phorbol esters, and H2O2 stimulate mitogen-activated protein kinase activity in NIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res. 54: 12–15.
Reid, T. M., and L. A. Loeb. 1993. Tandem double CC → TT mutations are produced by reactive oxygen species. Proc. Natl. Acad. Sci. USA 90: 3904–3907.
Hruza, L. L., and A. P. Pentland. 1993. Mechanisms of UV-induced inflammation. J. Invest. Dermatol. 100: 35S–41S.
Trenam, C. W., D. R. Blake, and C. J. Morris. 1992. Skin inflammation: reactive oxygen species and the role of iron. J. Invest. Dermatol. 99: 675–682.
Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein-and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7: 2135–2148.
Baeuerle, P. A., and D. Baltimore. 1989. A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB. Genes Dev. 3: 1689–1698.
Baeuerle, P. A., and D. Baltimore. 1988.1 kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242: 540–546.
Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53: 211–217.
Baeuerle, P. A., M. Lenardo, J. W. Pierce, and D. Baltimore. 1988. Phorbol-esterinduced activation of the NF-kappa B transcription factor involves dissociation of an apparently cytoplasmic NF-kappa B/inhibitor complex. Cold Spring Harbor Symp. Quant. Biol. 53(2): 789–798.
Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben Neriah, and P. Baeuerle. 1993. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365: 182–185.
Li, S., and J. M. Sedivy. 1993. Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-I kappa B complex. Proc. Natl. Acad. Sci. USA 90: 9247–9251.
Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10: 2247–2258.
Schreck, R., K. Albermann, and P. A. Baeuerle. 1992. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad. Res. Commun. 17: 221–237.
Schreck, R., H. Zorbas, G. L. Winnacker, and P. A. Baeuerle. 1990. The NF-kappa B transcription factor induces DNA bending which is modulated by its 65-kD subunit. Nucleic Acids Res. 18: 6497–6502.
Toledano, M. B., D. Ghosh, F. Trinh, and W. J. Leonard. 1993. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65. Mol. Cell. Biol. 13: 852–860.
Lin, A., T. Smeal, B. Binetruy, T. Deng, J. C. Chambard, and M. Karin. 1993. Control of AP-1 activity by signal transduction cascades. Second Messenger Phosphoprotein Res. 28: 255–260.
Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cellproliferation and transformation. Biochim. Biophys. Acta 1072: 129–157.
Skroch, P., C. Buchman, and M. Karin. 1993. Regulation of human and yeast metallothionein gene transcription by heavy metal ions. Prog. Clin. Biol. Res. 380: 113–128.
Chiu, R., M. Imagawa, R. J. Imbra, J. R. Bockoven, and M. Karin. 1987. Multiple-cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature 329: 648–651.
Okuno, H., A. Akahori, H. Sato, S. Xanthoudakis, T. Curran, and H. Iba. 1993. Escape from redox regulation enhances the transforming activity of Fos. Oncogene 8: 695–701.
Meyer, M., R. Schreck, and P. A. Baeuerle. 1993. H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells. AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005–2015.
Rushmore, T. H., R. G. King, K. E. Paulson, and C. B. Pickett. 1990. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. USA 87: 3826–3830.
Filling, R. S., A. Bensimon, Y. Tichauer, and V. Daniel. 1990. Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element. Proc. Natl. Acad. Sci. USA 87: 6258–6262.
Li, Y., and A. K. Jaiswal. 1992. Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J. Biol. Chem. 267: 15097–15104.
Pinkus, R., S. Bergelson, and V. Daniel. 1993. Phenobarbital induction of AP-1 binding activity mediates activation of glutathione S-transferase and quinone reductase gene expression. Biochem. J. 290: 637–640.
Storz, G., and L. A. Tartaglia. 1992. OxyR: a regulator of antioxidant genes. J. Nutr. 122: 627–630.
Wiese, A. G., R. E. Pacifici, and K. J. Davies. 1995. Transient adaptation of oxidative stress in mammalian cells. Arch. Biochem. Biophys. 318: 231–240.
Keyse, S. M., and E. A. Emslie. 1992. Oxidative stress and heat shock induce a human gene encoding a protein-tyrosine Phosphatase. Nature 359: 644–647.
Rao, G. N., B. Lassègue, K. K. Griendling, and R. W. Alexander. 1993. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene 8: 2759–2764.
Nose, K., M. Shibanuma, K. Kikuchi, H. Kageyama, S. Sakiyama, and T. Kuroki. 1991. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J. Biochem. 201: 99–106.
Palomba, L., P. Sestili, F. Cattabeni, A. Azzi, and O. Cantoni. (1996). Prevention of necrosis and activation of apoptosis in oxidatively injured human myeloid leukemia U937 cells. FEBS Lett. 390: 91–94.
Cantoni, O., F. Cattabeni, V. Stocchi, R. E. Meyn, P. Cerutti, and D. Murray. 1989. Hydrogen peroxide insult in cultured mammalian cells: relationships between DNA single-strand breakage, poly(ADP-ribose) metabolism and cell killing. Biochim. Biophys. Acta 1014: 1–7.
Mello Filho, A. C., M. E. Hoffmann, and R. Meneghini. 1984. Cell killing and DNA damage by hydrogen peroxide are mediated by intracellular iron. Biochem. J. 218: 273–275.
Schraufstatter, I. U., P. A. Hyslop, D. B. Hinshaw, R. G. Spragg, L. A. Sklar, and C. G. Cochrane. 1986. Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc. Natl Acad. Sci. USA 83: 4908–4912.
Junod, A. F., L. Jornot, and H. Petersen. 1989. Differential effects of hyperoxia and hydrogen peroxide on DNA damage, polyadenosine diphosphate-ribose polymerase activity, and nicotinamide adenine dinucleotide and adenosine triphosphate contents in cultured endothelial cells and flbroblasts. J. Cell. Physiol. 140: 177–185.
Kirkland, J. B. 1991. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase. Biochim. Biophys. Acta 1092: 319–325.
Schraufstatter, I. U., D. B. Hinshaw, P. A. Hyslop, R. G. Spragg, and C. G. Cochrane. 1986. Oxidant injury of cells. DNA strand-breaks activate polyadenosine diphosphate-ribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J. Clin. Invest. 77: 1312–1320.
Hyslop, P. A., D. B. Hinshaw, I. U. Schraufstatter, L. A. Sklar, R. G. Spragg, and C. G. Cochrane. 1986. Intracellular calcium homeostasis during hydrogen peroxide injury to cultured P388D1 cells. J. Cell Physiol 129: 356–366.
Lennon, S. V., J. J. Martin, and T. G. Cotter. 1991. Dose-dependent induction of apoptosis in human tumour cell lines by widely diverging stimuli. Cell Prolif. 24: 203–214.
Lennon, S. V., S. A. Kilfeather, M. B. Hallett, A. K. Campbell, and T. G. Cotter. 1992. Elevations in cytosolic free Ca2+ are not required to trigger apoptosis in human leukaemia cells. Clin. Exp. Immunol. 87: 465–471.
Ueda, N., and S. V. Shah. 1992. Endonuclease-induced DNA damage and cell death in oxidant injury to renal tubular epithelial cells. J. Clin. Invest. 90: 2593–2597.
Nosseri, C., S. Coppola, and L. Ghibelli. 1994. Possible involvement of poly(ADP-ribosyl) polymerase in triggering stress-induced apoptosis. Exp. Cell Res. 212: 367–373.
Weissberg, P. L. 1991. Mechanisms of vascular smooth muscle cell proliferation. Ann. Acad. Med. Singapore 20: 38–42.
Schwartz, S. M., G. R. Campbell, and J. H. Campbell. 1986. Replication of smooth muscle cells in vascular disease. Circ. Res. 58: 427–444.
Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809.
Schwartz, C. J., A. J. Valente, E. A. Sprague, J. L. Kelley, and R. M. Nerem. 1991. The pathogenesis of atherosclerosis: an overview. Clin. Cardiol. 14: 11–16.
Fridovich, I. 1978. The biology of oxygen radicals. Science 201: 875–880.
Halliwell, B. 1989. Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br. J. Exp. Pathol. 70: 737–757.
Redl, H., H. Gasser, G. Schlag, and I. Marzi. 1993. Involvement of oxygen radicals in shock related cell injury. Br. Med. Bull. 49: 556–565.
Ambrosio, G., J. L. Zweier, C. Duilio, P. Kuppusamy, G. Santoro, P. P. Elia, J. Tritto, P. Cirillo, M. Condorelli, and M. Chiariello. 1993. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J. Biol. Chem. 268: 18532–18541.
Horton, J. W., and P. B. Walker. 1993. Oxygen, radicals, lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. J. Appl. Physiol. 74: 1515–1520.
Granger, D. N., P. R. Kvietys, and M. A. Perry. 1993. Leukocyte—endothelial cell adhesion induced by ischemia and reperfusion. Can. J. Physiol. Pharmacol. 71: 67–75.
Kontos, H. A., E. P. Wei, J. T. Povlishock, and C. W. Christman. 1984. Oxygen radicals mediate the cerebral arteriolar dilation from arachidonate and bradykinin in cats. Circ. Res. 55: 295–303.
Malviya, A. N., and P. Anglard. 1986. Modulation of cytosolic protein kinase C activity by ferricyanide: priming event seems transmembrane redox signalling. A study on transformed C3H/10T1/2 cells in culture. FEBS Lett. 200: 265–270.
Xanthoudakis, S., and T. Curran. 1992. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653–665.
Staal, F. J., M. Roederer, and L. A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc. Natl Acad. Sci. USA 87: 9943–9947.
Dartsch, P. C., R. Voisard, and E. Betz. 1990. In vitro growth characteristics of human atherosclerotic plaque cells: comparison of cells from primary stenosing and restenosing lesions of peripheral and coronary arteries. Res. Exp. Med. 190: 77–87.
Dartsch, P. C., R. Voisard, G. Bauriedel, B. Hofling, and E. Betz. 1990. Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions. Arteriosclerosis 10: 62–75.
van Poppel, G., A. Kardinaal, H. Princen, and F. J. Kok. 1994. Antioxidants and coronary heart disease. Ann. Med. 26: 429–434.
Lafont, A. M., Y. C. Chai, J. F. Cornhill, P. L. Whitlow, P. H. Howe, and G. M. Chisolm. 1995. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J. Clin. Invest. 95: 1018–1025.
Haramaki, N., L. Packer, H. Assadnazari, and G. Zimmer. 1993. Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochem. Biophys Res. Commun. 196: 1101–1107.
Grainger, D. J., H. L. Kirschenlohr, J. C. Metcalfe, P. L. Weissberg, D. P. Wade, and R. M. Lawn. 1993. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 260: 1655–1658.
Buhler, F. R., V. A. Tkachuk, A. W. Hahn, and T. J. Resink. 1991. Low-and highdensity lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J. Hypertens. Suppl 9: S28–S36.
Ohlstein, E. H., S. A. Douglas, C. P. Sung, T. L. Yue, C. Louden, A. Arleth, G. Poste, R. R. Ruffolo, Jr., and G. Z. Feuerstein. 1993. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc. Natl. Acad. Sci. USA 90: 6189–6193.
Tasinato, A., D. Boscoboinik, G. M. Bartoli, P. Maroni, and A. Azzi. 1995. d-α-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. USA 92: 12190–12194.
Pryor, A. W., J. A. Cornicelli, L. J. Devall, B. Tait, B. K. Trivedi, D. T. Witiak, and M. Wu. 1993. A rapid screening test to determine the antioxidant potencies of natural and synthetic antioxidants. J. Org. Chem. 58: 3521–3532.
Azzi, A., D. Boscoboinik, D. Marilley, N. K. Özer, B. Stäuble, and A. Tasinato. 1995. Vitamin E: A sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. 62: 1337S–1346S.
Azzi, A., O. Cantoni, N. Ozer, D. Boscoboinik, and S. Spycher. 1996. The role of hydrogen peroxide and RRR-α-tocopherol in smooth muscle cell proliferation. Cell Death Differen. 3: 79–90.
Pears, C., S. Stabel, S. Cazaubon, and P. J. Parker. 1992. Studies on the phosphorylation of protein kinase C-alpha. Biochem. J. 283: 515–518.
Newton, A. C. 1995. Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270: 28495–28498.
Clarke, P. R., S. R. Siddhanti, P. Cohen, and P. J. Blackshear. 1993. Okadaic acidsensitive protein phosphatases dephosphorylate MARKS, a major protein kinase C substrate. FEBS Lett. 336: 37–42.
Clowes, A. W., and S. M. Schwartz. 1985. Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ. Res. 56: 139–145.
Traber, M. G., L. L. Rudel, G. W. Burton, L. Hughes, K. U. Ingold, and H. J. Kayden. 1990. Nascent VLDL from liver perfusions of cynomolgus monkeys are preferentially enriched in RRR-compared with SRR-alpha-tocopherol: studies using deuterated tocopherols. J. Lipid Res. 31: 687–694.
Burton, G. W., and K. U. Ingold. 1989. Vitamin E as an in vitro and in vivo antioxidant. Ann. N.Y. Acad. Sci. 570: 7–22.
Kanno, T., T. Utsumi, H. Kobuchi, Y. Takehara, J. Akiyama, T. Yoshioka, A. A. Horton, and K. Utsumi. 1995. Inhibition of stimulus-specific neutrophil Superoxide generation by alpha-tocopherol. Free Rad. Res. 22: 431–440.
Suzuki, Y. J., and L. Packer. 1993. Inhibition of NF-kappa B activation by vitamin E derivatives. Biochem. Biophys. Res. Commun. 193: 277–283.
Yoshioka, K., T. Deng, M. Cavigelli, and M. Karin. 1995. Antitumor promotion by phenolic antioxidants: inhibition of AP-1 activity through induction of Fra expression. Proc. Natl Acad. Sci. USA 92: 4972–4976.
Morisaki, N., J. A. Lindsey, J. M. Stitts, H. Zhang, and D. G. Cornwell. 1984. Fatty acid metabolism and cell proliferation. V. Evaluation of pathways for the generation of lipid peroxides. Lipids 19: 381–394.
Hennekens, C. H., and J. M. Gaziano. 1993. Antioxidants and heart disease: epidemiology and clinical evidence. Clin. Cardiol. 16: 10–13.
Boscoboinik, D., E. Chatelain, G. M. Bargoli, and A. Azzi. 1992. Molecular basis of alpha-tocopherol inhibition of smooth muscle cell proliferation in vitro, pp. 164–177. In I. Emerit and B. Chance (eds.). Free Radicals and Aging. Birkhäuser Verlag, Basel, Switzerland.
Boscoboinik, D., N. K. Özer, U. Moser, and A. Azzi. 1995. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. Arch. Biochem. Biophys. 318: 241–246.
Boscoboinik, D., A. Szewczyk, and A. Azzi. 1991. Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286: 264–269.
Boscoboinik, D., A. Szewczyk, C. Hensey, and A. Azzi. 1991. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266: 6188–6194.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Azzi, A. et al. (1997). Modulation by Oxidants and Antioxidants of Signal Transduction and Smooth Muscle Cell Proliferation. In: Forman, H.J., Cadenas, E. (eds) Oxidative Stress and Signal Transduction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5981-8_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5981-8_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7741-2
Online ISBN: 978-1-4615-5981-8
eBook Packages: Springer Book Archive